Home Featured Page 218

Featured

Latest

The State of the Psychedelic Industry & Open Questions (Video)

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...

Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life

PTSF83 – Abuse in Psychedelics: Complicity and Groupthink

Addressing Abuse in Psychedelic Spaces

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol...

Awakn Life Sciences Identifies New Chemical Series via Its Drug Discovery...

Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program

MYND Life Sciences Signs Agreement to Acquire Rights for the Use...

Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials

Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties...

World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as...

Silo Pharma Enters into Sponsored Research Agreement with Columbia University to...

EDITOR PICKS

The State of the Psychedelic Industry & Open Questions (Video)

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The State of the Psychedelic Industry & Open Questions (Video)

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...

Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life

PTSF83 – Abuse in Psychedelics: Complicity and Groupthink

Addressing Abuse in Psychedelic Spaces

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol...

Awakn Life Sciences Identifies New Chemical Series via Its Drug Discovery...

Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program

MYND Life Sciences Signs Agreement to Acquire Rights for the Use...

Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials

Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties...

World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as...

Silo Pharma Enters into Sponsored Research Agreement with Columbia University to...

EDITOR PICKS

The State of the Psychedelic Industry & Open Questions (Video)

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY